Immunohistochemical analysis of apocrine breast lesions

Pathology Research and Practice

Volumn 193, Issue 11-12, 1997, Pages 753-758

  Gatalica, Zoran ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Apocrine breast lesions; Steroid hormones receptors

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; STEROID RECEPTOR;

ADULT; AGED; APOCRINE CARCINOMA; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA;

EID: 0031409463     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(97)80053-2     Document Type: Article

References (24)

1. Albonico G, Querzoli P, Ferretti S, Magri F, Nenci I (1996) Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters. Path Res Pract 192: 117-123
2. Birrell SN, Bentell JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative response in human breast cancer cell lines. J Steroid Biochem Molec Biol 52: 459-467
3. Done SJ, Arneson NCR, Ozcelik H, Redston M, Andrulis IL (1997) Tissue microdissection to study homogeneity of p53 mutation in multistep brest tumorigenesis. Mod Pathol 10: 17A
4. Eusebi V, Damiani S, Losi L, Millis RR (1997) Apocrine differentiation in breast epithelium. Advances in Anatomic Pathology 4: 139-155
5. Gatalica Z, Grujic S, Kovatich A, Petersen RO (1996) Metanephric adenoma: Histology, immunophenotype, cytogenetics, ultrastructure. Mod Pathol 9: 329-333
6. Hackenberg R, Hannig K, Beck S, Schmidt-Rhode P, Scholz A, Schulz KD (1996) Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells. Eur J Cancer 32A: 696-701
7. Hackenberg R, Schulz KD (1996) Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. J Steroid Biochem Molec Biol 56: 113-117
8. Haldar S, Negrini M, Monne M, Sabbioni, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54: 2095-2097
9. Hall RE, Birrell SN, Tilley WD, Sutherland RL (1994) MDA-MB-453, and androgen responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer 30A: 484-490
10. Isola JJ (1993) Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170: 31-35
11. Iwamura M, Abrahamson P-A, Benning CM, Cockett ATK, Di Sant'Agnese A (1994) Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin embedded sections after microwave treatment. J Histochem Cytochem 42: 783-788
12. Karameris AM, Worthy E, Gorgoulis G, Quezados M, Anastassiades TH (1995) p53 gene alterations in special types of breast carcinoma: A molecular and immunohistochemical study in archival material. J Pathol 176: 361-372
13. Kuenen-Boumeester V, van der Kwast Th, van Putten WLJ, Claassen C, van Ooijen B, Henzen-Logmans SC (1992) Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer 52: 581-584
14. Miller WR, Telford J, Dixon JM, Shivas AA (1985) Androgen metabolism and apocrine differentiation in human breast cancer. Breast Can Res Treat 5: 67-73
15. O'Malley FP, Page DL, Nelson EH, DuPont WD (1994) Ductal carcinoma in situ of the breast with apocrine cytology. Human Path 25: 164-168
16. Pagani A, Sapino A, Eusebi V, Bergnolo P, Busolati G (1994) PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Archiv 425: 459-465
17. Page DL, DuPont WD, Jensen RA (1996) Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast carcinoma. Cancer Ep Biom Prev 5: 29-32
18. Raju U, Zarbo RJ, Kubus J, Schultz DS (1993) The histologic spectrum of apocrine breast proliferations. Human Path 24: 173-181
19. Rosen PP (1997) Cystic and papillary apocrine metaplasia. In: Rosen PP. Rosen's Breast pathology, p83-88. Lippincott-Raven, Philadelphia-New York
20. Rosen PP (1997) Apocrine carcinoma. In: Rosen PP. Rosen's breast pathology, p421-430. Lippincott-Raven, Philadelphia-New York
21. Tavassoli FA (1992) Apocrine metaplasia. In: Tavassolli FA. Pathology of the breast, p85-88. Appleton & Lange, Norwalk, CT
22. Tavasolli FA, Norris HJ (1994) Intraductal apocrine carcinoma: A clinicopathologic study of 37 cases. Modern Path 7: 813-818
23. Tavassoli FA, Purcell CA, Bratthauer GL, Man Y (1996) Androgen receptor expression along with the loss of bcl-2, ER and PR expression in benign and malignant apocrine lesions of the breast: Implications for therapy. The Breast Journal 2: 261-269
24. Visscher DW, Sarkar F, Tabaczka P, Crisman J (1996) Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma. Mod Pathol 9: 642-646